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Biocatalytic conversion of epoxides
Erik J de Vries and Dick B Janssen
Epoxides are attractive intermediates for producing chiral
compounds. Important biocatalytic reactions involving epoxides
include epoxide hydrolase mediated kinetic resolution, leading to
the formation of diols and enantiopure remaining substrates, and
enantioconvergent enzymatic hydrolysis, which gives high yields
of a single enantiomer from racemic mixtures. Epoxides can also
be converted by non-hydrolytic enantioselective ring opening,
using alternative anionic nucleophiles; these reactions can be
catalysed by haloalcohol dehalogenases. The differences in
scope of these enzymatic conversions is related to their different
catalytic mechanisms, which involve, respectively, covalent
catalysis with an aspartate carboxylate as the nucleophile and
non-covalent catalysis with a tyrosine that acts as a general acid-
base. The emerging new possibilities for enantioselective
biocatalytic conversion of epoxides suggests that their
importance in green chemistry will grow.
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Because of the intrinsic reactivity of the epoxide ring,
epoxides are valuable intermediates in the production of
high added-value chemicals like pharmaceuticals. Race-
mic mixtures of epoxides can be used to prepare enan-
tiopure epoxides by kinetic resolution and a range of
chemical [1] and biocatalytic [2] procedures are available
for this purpose. Epoxides are attractive for further deri-
vatization because they readily react with halides, carbon,
nitrogen, oxygen or sulfur nucleophiles. For example, the
conversion of glycidol derivatives with amines is a useful
step during the preparation of various b-blockers. It has
been demonstrated that at least some of these coupling
reactions have an enzyme-catalysed equivalent. Biocat-
alytic epoxide conversion can proceed by hydrolysis,
conjugation to thiol cofactors, and through nucleophilic
ring opening. The most important enzyme classes are
shown in Table 1.
Several interesting concepts that have been developed
over the past years for other biocatalysts might also be
applicable for the enzymatic conversion of epoxides. One
attractive possibility would be to tailor the nucleophile
in epoxide ring-opening reactions. With lipases and
esterases, for instance, this can be used (in organic solvents)
to prepare amides by adding an amine to the reaction
mixture [3]. Similarly, glycosidases can couple a sugar
moiety to an alcohol [4,5] and penicillin acylases can be
used for the resolution of amines through acylation [6]. In
some cases,protein engineering by mutagenesis or directed
evolution has resulted in dramatically altered enzymatic
activities, yielding enzymes that form different reaction
products compared with wild-type enzymes [7,8]. It is
desirable to expand the current biosynthetic toolbox for
epoxide conversion by finding new enzymes or by applying
the above-mentioned concepts to broaden the scope and
performance of existing epoxide-converting biocatalysts.
Here we present recent advances in the biocatalytic con-
version of epoxides. We describe the mechanisms of epox-
ide-converting enzymes and discuss the use of different
nucleophiles in enzymatic ring-opening reactions.
Epoxide ring opening with water using
epoxide hydrolase
The hydrolysis of epoxides to the corresponding diols
with epoxide hydrolases has been well described [9,
10,11]. It is known that epoxides can be opened by direct
attack of the nucleophile on the epoxide ring or via an
intermediate in which there is a covalent link between
the enzyme and the substrate (covalent catalysis). Most
epoxide hydrolases belong to the a/b-hydrolase fold
family of enzymes, which also encompasses many lipases,
esterases and dehalogenases. The mechanism of epoxide
hydrolase from Agrobacterium radiobacter AD1 is shown in
Figure 1a [12]. The Aspergillus niger enzyme has a similar
structure and mechanism [13]. The enzymes possess a
catalytic triad, of which the nucleophilic aspartate carries
out an attack on the carbon atom of the epoxide ring,
displacing the oxygen and producing a covalent inter-
mediate. Hydrolysis of this intermediate by water is
facilitated by a histidine residue. This regenerates the
enzyme and gives the product as a diol of which one of the
oxygen atoms originates from the enzyme.
It is assumed that in most cases the proton transfer to the
oxygen of the substrate is concerted with the attack of the
aspartate or that it immediately follows the ring opening.
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If electron withdrawing or donating effects of the para-
substituent on the aromatic ring affect the rate-limiting
step, this should give a clear correlation in a so-called
Hammett plot where the relative reaction rate is plotted
versus the Hammett constant sp, which represents the
electron-withdrawing effect of the ring substituent. How-
ever, Hammett plots of the hydrolysis of para-substituted
styrene oxides by some epoxide hydrolases did not show
this correlation, which was regarded as evidence for the
involvement of a general acid in catalysis, indicating
epoxide oxygen protonation as a distinct first step [14].
Proof for this mechanism was also obtained with a crude
rabbit liver microsome preparation [15], where protona-
tion by a general acid seemed to be the first step during
the conversion of norbornene-2,3-epoxide, as there was a
shift in the position of the hydroxyl in the product which
could only be explained by the transient formation of a
carbocation that has sufficient lifetime to allow a rear-
rangement to occur. Another explanation for the lack of a
correlation in a Hammett plot might be that the hydro-
lysis of the covalent intermediate rather than its formation
is the rate-limiting step, which is the case with at least
some substrates for the A. radiobacter enzyme [16].
Developments in the field of molecular biology and
advances in high-throughput screening methods [17]
continue to increase the number and amounts of available
epoxide hydrolase and also make it possible to improve
their properties. For screening of epoxide hydrolases with
improved enantioselectivity, the pseudo-enantiomers (S)-
glycidyl phenyl ether and (R)-D-5-glycidyl phenyl ether
were synthesized and used to quantify the enantiomeric
excess (ee) value by multichannel mass spectrometry [18].
However, mutants with improved enantioselectivity have,
thus far, only been obtained by structure-based site-
directed mutagenesis [19].
By screening a range of enzymes and mutants, the ones
that are most suited for the conversion of a specific
substrate can be selected [20]. This has led, for ins-
tance, to the availability of epoxide hydrolases for pyr-
idyloxiranes, which are notoriously difficult to prepare in
an optically pure form by chemical methods. Using
epoxide hydrolase from A. niger [21] or a mutated A.
radiobacter enzyme [19], resolution of 2-, 3-, and 4-
pyridyloxirane was obtained on a scale of up to 36 g/l.
By selecting the correct enzymes, enantioconvergent
hydrolysis can be obtained, which is based on different
regioselectivities for the different enantiomers [22], and
allows isolation of the diols in more than 50% yield. The
strength of this concept is demonstrated in the hydro-
lysis of aliphatic trisubstituted epoxides: with Strepto-
myces lavendulae epoxide hydrolase the diol was obtained
in 60% yield with an ee of 97% and a Rhodococcus ruber
enzyme gave 85% yield with an ee of 85% [23]. A
further example concerns the production of para-chlor-
ostyrene epoxide [24]. In this case, the (S)-enantiomer of
the racemic mixture was hydrolyzed by Solanum tuber-
osum EH which forms the (R)-diol by attack on the
benzylic position, inverting the stereochemistry. In a
consecutive step with A. niger EH the unreacted (R)-
enantiomer that was left behind reacts on the least
substituted carbon atom to also form the (R)-diol. Using
this strategy, the (R)-diol could be isolated in 93% yield
with an ee of 96%.
The use of epoxides in biocatalytic processes causes
some challenges related to the chemical properties of
epoxides. Several substrates are poorly soluble and the
reactivity of the epoxide ring can cause chemical hydro-
lysis. As a remedy, the substrate can be added as a solid or
in a liquid phase. Another method uses octane as a second
phase, which dissolves the epoxide. This approach
Table 1
Important enzyme-catalysed conversions of epoxides in microorganisms.
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allowed the enantioselective hydrolysis of styrene oxide
on a 39 g/l scale with good yields of the remaining
(S)-enantiomer [25]. Immobilization techniques can
enhance the enzyme stability, change the catalytic prop-
erties, and facilitate the recycling of the biocatalyst. A
flow-through membrane reactor can be used to retain
enzyme and cosolvents to improve substrate solubility
[26]. From the low ee values that were obtained, and the
observation that enzyme inactivation occurred if the
cosolvent (ethanol, acetonitrile) concentration was above
20%, it can be concluded that reactor aspects need to be
improved further. Imprinting the enzyme with a sub-
strate in the immobilization process can influence the
enantioselectivity. Rhodotorula glutinis EH was imprinted
with (S)-1,2-epoxyoctane before immobilization and it
was found that the enantiospecificity in the hydrolysis of
the racemic mixture of this substrate changed from
(R)-specific to (S)-specific, albeit with low enantioselec-
tivity, changing from E ¼ 1.3 (R) to 1.8 (S) [27]. The
E-value allows for the easy comparison of enantioselec-
tive processes, and is defined as the ratio of the kcat/Km
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Reaction mechanisms of epoxide-converting enzymes. (a) Ring opening of styrene oxide by epoxide hydrolases from A. radiobacter. Step 1,
nucleophilic attack of Asp107 yielding a covalent intermediate. Step 2, hydrolysis of the covalent intermediate by water, assisted by His275. (b) Non-
covalent catalytic mechanism of leukotriene A4 epoxide hydrolase. Ring opening is facilitated by a zinc atom. (c) Reversible ring opening of an epoxide
by A. radiobacter haloalcohol dehalogenase. The arginine–tyrosine pair is involved in leaving group protonation.
416 Protein technologies and commercial enzymes
Current Opinion in Biotechnology 2003, 14:414–420 www.current-opinion.com
Epoxide ring opening with other nucleophiles
It would be attractive to be able to use nucleophiles other
than water, for example, in the synthetic concepts men-
tioned in the introduction and in enantioselective kinetic
resolutions. To our knowledge, no examples of using
other nucleophilic agents with epoxide hydrolases have
been reported. This is probably related to the mechanism
of the ab-hydrolase fold enzymes. For instance, replacing
water in step 2 (Figure 1a) with ammonia would, after one
turnover, change Asp192 into Asn192, which is not a
suitable nucleophile for catalysis. An inactive Asp!Asn
mutant reverts back to wild type by slow hydrolysis
(t1/2 ¼ 9.3 days) of the asparagine to aspartate [28]. This
same turnover-related inactivation by ammonia is found
in the fluoroacetate dehalogenase, which also uses a
nucleophilic aspartate [29]. With this class of epoxide
hydrolase, the covalent intermediate is always attacked at
the carbonyl functionality of the enzyme and, unless the
mechanism of breaking the covalent intermediate
changes to attack on the substrate carbon atom, it is only
possible to prepare vicinal diols.
There are epoxide hydrolases that act through a different
mechanism. In the fungus Fusarium solani pisi cis-hydra-
tion of the epoxide occurs [30]. Based on inhibition
studies, a cysteine residue was postulated to attack the
epoxide ring, with inversion, to form a thioether inter-
mediate. Attack of water at the same carbon atom results
in inversion of stereochemistry again. Alternatively, the
concept of covalent catalysis may be abandoned comple-
tely. In ring opening through non-covalent catalysis, the
epoxide ring will be activated by interacting with certain
groups of the enzyme, and ring opening will rely on the
reactivity of an activated nucleophile. The mechanism of
leukotriene A4 hydrolase is well known (Figure 1b) [31].
The expected vicinal diol is not formed owing to the nature
of the substrate, which allows a shift of the carbocation
intermediate. Other probable candidates for non-covalent
catalysis are limonene epoxide hydrolase from Rhodococcus
erythropolis [32] (see also Update) and cholesterol epoxide
hydrolase [33]. It is conceivable that with such different
enzymes alternative nucleophiles might be used.
Conversion of epoxides by haloalcohol
dehalogenases
Haloalcohol dehalogenases (also called halohydrin deha-
logenases or hydrogen-halide lyases) catalyse the rever-
sible dehalogenation of vicinal haloalcohols by an
intramolecular nucleophilic displacement of a halogen
to yield an epoxide and halide. These enzymes play a role
in the biodegradation of some xenobiotic halogenated
compounds. In Figure 1c, the proposed mechanism of
the reversible ring opening is shown, which is based on
the sequence similarity with the short-chain dehydro-
genase/reductase (SDR) family of proteins [34]. The
process involves activation of the epoxide by hydrogen
bonding to a tyrosine. As found in other dehalogenases
[35], the nucleophile is expected to bind in a halide-
binding pocket.
The use of haloalcohol dehalogenases for kinetic resolu-
tion of haloalcohols by an enantioselective ring closure
reaction is well documented [36] and this process is
applied on an industrial scale for the production of opti-
cally pure epichlorohydrin. The fact that a non-covalent
pathway is used suggests that it is easier to apply for the
reverse reaction. Until recently, only one example of the
reverse reaction with the alternative nucleophile cyanide,
resulting in b-hydroxynitriles, was described [37]. A
screening of possible nucleophiles accepted by the haloal-
cohol dehalogenase HheC from A. radiobacter has been
published [38]. A range of ionic and non-ionic nucleo-
philes were tested for their ability to react with a chro-
mogenic epoxide. Besides the nucleophiles Cl, Br and
I, the ambident nucleophiles N3
, NO2
 and CN were
also accepted by the enzyme. No conversion was
observed with non-ionic nucleophiles such as isopro-
pylamine and ethanol. This specificity of the enzymes
towards certain nucleophiles must be due to a selective
interaction in the halide-binding site. The non-halide
nucleophiles accepted by the haloalcohol dehalogenase
are ambident anions with a (close to) linear shape. This
suggests that the binding site of the nucleophile has the
shape of a tunnel and that binding at the non-reacting end
of the nucleophile is stabilized by groups that donate a
hydrogen bond.
Amino alcohols are important molecules and can be
prepared from the azido alcohol through reduction.
The ring opening of para-substituted styrene oxides by
azide using haloalcohol dehalogenase was studied in
detail [39]. Catalysis occurred with high b-regioselectivity
and enantioselectivity (E > 200) towards the (R)-epoxide,
resulting in the remaining (S)-epoxides and the formed
(R)-2-azido-1-phenylethanols in high optical purity. The
reaction was irreversible, as azide is a very poor leaving
group. The regioselectivity towards the b-carbon atom is
remarkable as it is opposite to the observed regioselec-
tivity in the non-enzyme catalysed chemical ring opening.
A first attempt at scale-up in which the azide was slowly
added and para-nitrostyrene oxide was present as a solid
second phase (7.8 g/l) yielded (S)-para-nitrostyrene oxide
in 46% yield and 98% ee and the (R)-2-azido alcohol in
47% yield and 97% ee.
The nature of the product formed by ring opening with
nitrite is not yet known. However, on the basis of the
proposed shape of the halide-binding site, the formation
of a nitrite ester is more likely than the formation of a
nitro-compound. Further investigations of this mech-
anism by crystallographic studies are currently under
way [40]. Based on the outcome of this study, the
halide-binding site might be modified through site-
directed mutagenesis to accept other nucleophiles.
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With the nucleophiles that are known to be accepted by
haloalcohol dehalogenases, it is possible to prepare enan-
tiomerically pure haloalcohols, b- and g-amino alcohols,
b-hydroxynitriles and, thus, b-hydroxy amides and acids
(Figure 2).
Other epoxide-converting enzymes
Several other routes for the microbial conversion of
epoxides have been described. Glutathione S-trans-
ferases (GSTs) are involved in the detoxification of com-
pounds by their conjugation to the tripeptide glutathione
(g-Glu-Cys-Gly), followed by further metabolization.
Two distinct mechanisms are found for the conjugation
of epoxides with glutathione. The most common one
relies on hydrogen bonding of the thiol group of glu-
tathione to suitable groups on the enzyme, making it
more nucleophilic. Alternatively, complexation of the
epoxide ring of the substrate to a metal ion like Mn(II)
makes it more electrophilic, facilitating attack of glu-
tathione [41]. In general, GSTs have a large solvent-
exposed active site and, thus, a broad specificity. Over
the past few years more microbial enzymes have become
available. Their role in epoxide metabolism is still unclear
and it is not known if these enzymes can be applied in
enantioselective biocatalysis. The regioselectivity of ring
opening has been studied for the conjugation of isoprene
epoxides, but whether the reactions proceed with enan-
tioselectivity was not established rigorously [42,43]. FosA
is a member of the second group of glutathione trans-
ferases, using a metal ion for substrate-epoxide ring
activation. In the detoxification of fosfomycin by ring
opening, glutathione can be replaced by cysteine [44–46].
Epoxides are common intermediates in the microbial
degradation of alkenes. In these cases, epoxide conver-
sion can proceed via carboxylation, which is catalysed by a
four-component multi-enzyme system that couples epox-
ides with carbon dioxide to form b-keto carboxylic acids
[47,48]. This reaction requires cofactor M (CoM, 2-mer-
capto-1-ethyl sulfonate) [49,50]. The system was found to
enantioselectively degrade 2,3-epoxybutane [51], but not
epoxypropane. Component 1 of the carboxylase system
has been isolated and purified; it is a zinc-containing
hexamer performing a nucleophilic ring opening with
CoM. Analysis of the isolated intermediate showed that
the reaction occurs selectively at the least hindered
carbon atom. Incubations of the racemate and the sepa-
rate enantiomers revealed only a slight enantioprefer-
ence: (R)-propylene oxide reacted twice as fast as (S)-
propylene oxide. Other thiols, such as mercaptoethanol,
cysteine, glutathione or 3-mercapto-1-propane sulfonate
were not active as a nucleophile [52].
Conclusions
The use of new methods for screening and selection of
enzymes as well as the exploitation of unusual microbial
sources has rapidly expanded the biocatalytic scope of
epoxide-converting enzymes. The diversity of available
enantioselective epoxide hydrolases has increased. New
reactions have been found for haloalcohol dehalogenases,
including enantioselective enzymatic azidolysis. The
range of substrates for which attractive applications have
been demonstrated is increasing. This justifies the con-
clusion that the importance of epoxides in green chem-
istry routes for the enantioselective preparation of fine
chemicals will quickly grow.
Update
Recently, a protein crystallographic study showed that
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Conversions of epoxides by haloalcohol dehalogenase and their biocatalytic potential. Enzymatic azidolysis (step 1) followed by reduction (step 2)
gives b-amino alcohols. The product of enzymatic ring opening with nitrite (step 3) is not clear, it gives either the nitrite ester (nucleophilic O-attack) or
the nitro alcohol (nucleophilic N-attack). Ring opening with cyanide (step 4) yields a b-cyanohydrin, which can be partially hydrolyzed to the amide
(step 6), completely hydrolyzed to the acid (step 5) or reduced to the g-amino alcohol (step 7).
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acts through a one-step mechanism involving the proto-
nation of the epoxide ring by aspartate 101 with conco-
mitant attack of a water molecule on a carbon atom of the
epoxide ring [53]. A study into the pre-steady state and
steady state kinetics of the ring closure of haloalcohols by
the haloalcohol dehalogenase of A. radiobacter AD1 led to
a better understanding of the enantioselectivity of this
enzyme [54].
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